Index
1 Market Overview
1.1 Product Overview and Scope of Rare Genetic Disease Diagnosis Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Rare Genetic Disease Diagnosis Solution by Type
1.3.1 Overview: Global Rare Genetic Disease Diagnosis Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Rare Genetic Disease Diagnosis Solution Consumption Value Market Share by Type in 2022
1.3.3 Genetic Testing
1.3.4 Biochemical Testing
1.3.5 Imaging and Diagnostic Procedures
1.3.6 Others
1.4 Global Rare Genetic Disease Diagnosis Solution Market by Application
1.4.1 Overview: Global Rare Genetic Disease Diagnosis Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinical Genetics and Pediatric Clinic
1.4.3 Newborn Screening Program
1.4.4 Research and Development
1.4.5 Others
1.5 Global Rare Genetic Disease Diagnosis Solution Market Size & Forecast
1.6 Global Rare Genetic Disease Diagnosis Solution Market Size and Forecast by Region
1.6.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Region, (2018-2029)
1.6.3 North America Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
1.6.6 South America Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Retrophin
2.1.1 Retrophin Details
2.1.2 Retrophin Major Business
2.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Product and Solutions
2.1.4 Retrophin Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Retrophin Recent Developments and Future Plans
2.2 3billion
2.2.1 3billion Details
2.2.2 3billion Major Business
2.2.3 3billion Rare Genetic Disease Diagnosis Solution Product and Solutions
2.2.4 3billion Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 3billion Recent Developments and Future Plans
2.3 23andMe
2.3.1 23andMe Details
2.3.2 23andMe Major Business
2.3.3 23andMe Rare Genetic Disease Diagnosis Solution Product and Solutions
2.3.4 23andMe Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 23andMe Recent Developments and Future Plans
2.4 Ancestry
2.4.1 Ancestry Details
2.4.2 Ancestry Major Business
2.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Product and Solutions
2.4.4 Ancestry Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ancestry Recent Developments and Future Plans
2.5 GeneDx
2.5.1 GeneDx Details
2.5.2 GeneDx Major Business
2.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Product and Solutions
2.5.4 GeneDx Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GeneDx Recent Developments and Future Plans
2.6 Ambry Genetics
2.6.1 Ambry Genetics Details
2.6.2 Ambry Genetics Major Business
2.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Product and Solutions
2.6.4 Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ambry Genetics Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Product and Solutions
2.7.4 QIAGEN Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Rare Genetic Disease Diagnosis Solution Product and Solutions
2.8.4 Illumina Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Illumina Recent Developments and Future Plans
2.9 PerkinElmer
2.9.1 PerkinElmer Details
2.9.2 PerkinElmer Major Business
2.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Product and Solutions
2.9.4 PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PerkinElmer Recent Developments and Future Plans
2.10 Strand Life Sciences
2.10.1 Strand Life Sciences Details
2.10.2 Strand Life Sciences Major Business
2.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product and Solutions
2.10.4 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Strand Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rare Genetic Disease Diagnosis Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Rare Genetic Disease Diagnosis Solution by Company Revenue
3.2.2 Top 3 Rare Genetic Disease Diagnosis Solution Players Market Share in 2022
3.2.3 Top 6 Rare Genetic Disease Diagnosis Solution Players Market Share in 2022
3.3 Rare Genetic Disease Diagnosis Solution Market: Overall Company Footprint Analysis
3.3.1 Rare Genetic Disease Diagnosis Solution Market: Region Footprint
3.3.2 Rare Genetic Disease Diagnosis Solution Market: Company Product Type Footprint
3.3.3 Rare Genetic Disease Diagnosis Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Rare Genetic Disease Diagnosis Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Rare Genetic Disease Diagnosis Solution Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Rare Genetic Disease Diagnosis Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Rare Genetic Disease Diagnosis Solution Market Forecast by Application (2024-2029)
6 North America
6.1 North America Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
6.2 North America Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
6.3 North America Rare Genetic Disease Diagnosis Solution Market Size by Country
6.3.1 North America Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
6.3.2 United States Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
7.2 Europe Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
7.3 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country
7.3.1 Europe Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
7.3.3 France Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region
8.3.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Consumption Value by Region (2018-2029)
8.3.2 China Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
8.3.5 India Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
9 South America
9.1 South America Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
9.2 South America Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
9.3 South America Rare Genetic Disease Diagnosis Solution Market Size by Country
9.3.1 South America Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country
10.3.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Rare Genetic Disease Diagnosis Solution Market Drivers
11.2 Rare Genetic Disease Diagnosis Solution Market Restraints
11.3 Rare Genetic Disease Diagnosis Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Rare Genetic Disease Diagnosis Solution Industry Chain
12.2 Rare Genetic Disease Diagnosis Solution Upstream Analysis
12.3 Rare Genetic Disease Diagnosis Solution Midstream Analysis
12.4 Rare Genetic Disease Diagnosis Solution Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer